id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2015-E-2582-0003,FDA,FDA-2015-E-2582,Letter from FDA CDER to the U.S. Patent and Trademark Office,Other,Letter(s),2015-10-15T04:00:00Z,2015,10,2015-10-15T04:00:00Z,,2015-10-15T20:19:26Z,,0,0,0900006481ccf1e3
FDA-2015-E-2582-0001,FDA,FDA-2015-E-2582,Patent Extension Application from  Boehringer Ingelheim USA Corp (on behalf of Boehringer Ingelheim Pharma GmbH & Co. KG ),Other,Application,2015-07-21T04:00:00Z,2015,7,2015-07-21T04:00:00Z,,2015-07-21T15:22:51Z,,0,0,0900006481b94f78
FDA-2015-E-2582-0002,FDA,FDA-2015-E-2582,Letter from U.S. Patent and Trademark Office,Other,Letter(s),2015-07-21T04:00:00Z,2015,7,2015-07-21T04:00:00Z,,2015-07-21T15:22:59Z,,0,0,0900006481b94881